BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Breast Cancer
,
Neuron
,
Alcohol
,
Rosiglitazone
,
rs3825942
,
BRAF
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SA node cell action potential
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tongue superior part with papillae
Pons
Fetal brain
Prefrontal cortex
Stomach pyloric
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Varicella-zoster virus infection
Pyloric ulcer
Vesicular stomatitis Indiana virus disease
Infection due to Citrobacter
Hypercapnia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
ilomastat
diacetylrhein
OTS-167
Glesatinib
BS-181
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
ZNF598
DIDO1
SPTLC1
MYH6
TLK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for SA node cell action potential
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects …
Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive B…
Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Tre…
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral An…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ